Clear Harbor Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Clear Harbor Asset Management's REGN Position: Q2 2026 in Review
Clear Harbor Asset Management reduced its Regeneron Pharmaceuticals (REGN) stake by 30% in Q2 2026, selling an estimated $2.22M and leaving 7,610 shares worth $4.75M. The position accounts for 0.29% of the portfolio, ranked #74.
Clear Harbor Asset Management first reported a position in REGN in Q1 2021 and has held it in 22 quarters since. The position peaked at $8.4M in Q1 2026. 1,341 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Clear Harbor Asset Management held 7,610 shares of Regeneron Pharmaceuticals worth $4.75M as of Q2 2026.
- Clear Harbor Asset Management sold 3,265 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.22M.
- Regeneron Pharmaceuticals made up 0.29% of Clear Harbor Asset Management's portfolio in Q2 2026, its #74 holding.
- Clear Harbor Asset Management first reported a position in Regeneron Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
- Clear Harbor Asset Management's Regeneron Pharmaceuticals position peaked at $8.4M in Q1 2026.
- 1,341 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Clear Harbor Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.